Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead Sags Despite Q1 Beat; Sees Cost from Health Reform
Barron's
Wed, 04/21/10 - 07:53 am
Tags:
Gilead Sciences, earnings
Gilead Sciences halts hepatitis C drug trials
Bizjournals.com
Tue, 04/20/10 - 10:44 am
Tags:
Gilead Sciences, clinical trials, hepatitis C
What’s Ahead for Biotech Earnings
Minyanville
Sat, 04/17/10 - 12:11 pm
Tags:
biotech, earnings, Amylin, Gilead Sciences, Biogen Idec, Amgen, Genzyme
Biotech Earnings: Large-Cap Preview
TheStreet.com
Wed, 04/14/10 - 10:46 am
Tags:
earnings, Amylin, Biogen Idec, Gilead Sciences, Vanda, Genzyme, Amgen, Alexion, Celgene, Allos
Gilead starts late stage tests of 4-in-1- HIV drug
Yahoo/AP
Mon, 04/12/10 - 06:14 pm
Tags:
Gilead Sciences, Quad, HIV, Abbott Laboratories
FDA warns Gilead, Biogen over drug promotions
Reuters
Thu, 04/8/10 - 09:49 am
Tags:
FDA, Biogen Idec, Tysabri, Gilead Sciences, Truvada
Will an AIDS Pill a Day Keep the Virus Away?
Businessweek
Fri, 04/2/10 - 09:13 am
Tags:
HIV, AIDS, Gilead Sciences, PrEP
Hey, CEO Pay Can Be Rational: Just Look at Gilead Sciences
BNET Pharma
Thu, 03/25/10 - 10:14 am
Tags:
executive pay, Gilead Sciences
Uptrend in Gilead's Estimates
Yahoo/Zacks.com
Fri, 03/5/10 - 09:48 am
Tags:
Gilead Sciences, GSK, Novartis
Gilead Science: Dominance in the HIV Market
Seeking Alpha
Mon, 03/1/10 - 09:29 am
Tags:
Gilead Sciences, HIV, Quad
U.S. Food And Drug Administration Approves Cayston(R) For The Improvement Of Respiratory Symptoms In Cystic Fibrosis Patients
Medical News Today
Sat, 02/27/10 - 12:42 pm
Tags:
Gilead Sciences, Cayston, cystic fibrosis
Gilead: A Step in the Right Direction
Seeking Alpha
Wed, 02/24/10 - 05:25 pm
Tags:
Gilead Sciences, Novartis, Cayston, cystic fibrosis
Gilead’s Inhaled Antibiotic for Lungs Wins Approval
Bloomberg
Tue, 02/23/10 - 11:14 am
Tags:
Gilead Sciences, Cayston, antibiotics, FDA, cystic fibrosis
Gilead Set to Benefit From Newest HIV Drug
Seeking Alpha
Thu, 02/18/10 - 08:45 pm
Tags:
Gilead Sciences, HIV, Teva Pharmaceuticals, Mylan, Merck, Pfizer, GSK, Abbott Laboratories, JNJ, Bristol-Myers Squibb
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 10:58 am
Tags:
FDA, Cadence Pharmaceuticals, Acorda Therapeutics, Auxilium, Gilead Sciences, Shire, Amylin, Cell Therapeutics, Dendreon, InterMune, Amgen, Human Genome, NicOx, Vivus, Arena Pharmaceuticals, Orexigen
4 Winning Biotechs For Your Portfolio: Senior Analyst
CNBC
Mon, 02/8/10 - 12:30 pm
Tags:
Amgen, Gilead Sciences, Dendreon, Acorda Therapeutics
Bargains to be found in health-care stocks
Yahoo/Fortune
Mon, 02/1/10 - 10:22 am
Tags:
Amgen, Genzyme, Gilead Sciences
Biotech Events to Watch in 2010: FDA Approvals, Expected Deals and Surprises!
BNET Pharma
Mon, 02/1/10 - 10:11 am
Tags:
biotech, FDA, Cadence Pharmaceuticals, Acetavance, Gilead Sciences, Cayston, velaglucerase, Shire, Exenatide LAR, Amylin, Cephalon, NUVIGIL, Cell Therapeutics, pixantrone, Dendreon, Provenge
Gilead to repurchase up to $1 billion shares
Marketwatch
Fri, 01/29/10 - 11:17 am
Tags:
stock buyback, Gilead Sciences
The Virus-Killer's Killer Quarter
Motley Fool
Wed, 01/27/10 - 09:46 pm
Tags:
Bristol-Myers Squibb, Gilead Sciences, Pfizer, GSK, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.